| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/12/2011 | WO2010137900A9 Selective infracted-tissue-targeting bacteria and use thereof |
| 05/12/2011 | WO2010135695A3 TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3 |
| 05/12/2011 | WO2010129861A3 Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family |
| 05/12/2011 | WO2010127166A4 Combination anti-hiv vectors, targeting vectors, and methods of use |
| 05/12/2011 | WO2010114948A3 An inducible system for highly efficient production of recombinant adeno-associated virus (raav) vectors |
| 05/12/2011 | WO2010093860A4 Isolation of factors that associate directly or indirectly with chromatin |
| 05/12/2011 | US20110113513 Soybean Isopentenyl Transferase Genes and Methods of Use |
| 05/12/2011 | US20110113512 Trichome specific promoters |
| 05/12/2011 | US20110113511 Viral promoter, truncations thereof, and methods of use |
| 05/12/2011 | US20110113510 Promoters from Brassica Napus for Seed Specific Gene Expression |
| 05/12/2011 | US20110113508 Modulating plant carotenoid levels |
| 05/12/2011 | US20110113507 Tomatoes That Soften More Slowly Post-Harvest Due To Non-Transgenic Alterations In An Expansin Gene |
| 05/12/2011 | US20110113504 Cotton Variety ST 4288B2F |
| 05/12/2011 | US20110113503 Compositions and Methods for Altering Alpha- And Beta- Tocotrienol Content Using Multiple Transgenes |
| 05/12/2011 | US20110113499 Altering Root Structure During Plant Development |
| 05/12/2011 | US20110113498 Sirt1 polymorphic variants and methods of use thereof |
| 05/12/2011 | US20110113494 Serine Hydroxymethyltransferase as Target for Herbicides |
| 05/12/2011 | US20110112990 Efficient Production of Peptides |
| 05/12/2011 | US20110112284 Methods for modulating ikkalpha activity |
| 05/12/2011 | US20110112283 Rna interference mediating small rna molecules |
| 05/12/2011 | US20110112279 Compositions and Methods Relating to STOP-1 |
| 05/12/2011 | US20110112276 Mutated immunoglobulin-binding protein |
| 05/12/2011 | US20110112178 Compositions And Methods For Inhibiting Expression Of IKK-B Gene |
| 05/12/2011 | US20110112177 Human G-Protein Coupled Receptor (HETGQ23) |
| 05/12/2011 | US20110112176 Compositions and methods for inhibiting expression of kif10 genes |
| 05/12/2011 | US20110112175 Peptide biosynthesis and pain therapy |
| 05/12/2011 | US20110112173 Methods and compositions involving microrna |
| 05/12/2011 | US20110112172 SDF-1 Binding Nucleic Acids |
| 05/12/2011 | US20110112170 Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity |
| 05/12/2011 | US20110112169 RNAi-BASED THERAPEUTICS FOR ALLERGIC RHINITIS AND ASTHMA |
| 05/12/2011 | US20110112167 Therapeutic agents and targets |
| 05/12/2011 | US20110112040 Supercharged proteins for cell penetration |
| 05/12/2011 | US20110112022 Factor VIII Muteins with Reduced Immonugenicity |
| 05/12/2011 | US20110112015 Use of glis3 for preparing functional pancreatic beta-cells |
| 05/12/2011 | US20110112013 Novel Bacillus thuringiensis Gene with Lepidopteran Activity |
| 05/12/2011 | US20110111985 Biosensor |
| 05/12/2011 | US20110111983 siRNA targeting spleen tyrosine kinase |
| 05/12/2011 | US20110111973 Broad specificity affinity arrays: a qualitative approach to complex sample discrimination |
| 05/12/2011 | US20110111528 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 05/12/2011 | US20110111505 Genetically engineered cells which express bone morphogenic proteins |
| 05/12/2011 | US20110111502 Elimination of immune responses to viral vectors |
| 05/12/2011 | US20110111496 BACTERIA-MEDIATED GENE MODULATION VIA microRNA MACHINERY |
| 05/12/2011 | US20110111494 Multimeric tnf receptors |
| 05/12/2011 | US20110111493 Compositions and Methods For Inhibiting Expression Of A Target Gene |
| 05/12/2011 | US20110111491 Rna interference suppresion of neurodegenerative diseases and methods of use thereof |
| 05/12/2011 | US20110111483 Optimizing Expression of Active Botulinum Toxin Type E |
| 05/12/2011 | US20110111464 Methods and compositions for cloning nucleic acid molecules |
| 05/12/2011 | US20110111461 Antigen Binding Molecules that Bind EGFR, Vectors Encoding Same, and Uses Thereof |
| 05/12/2011 | US20110111460 Method for Making Mature Insulin Polypeptides |
| 05/12/2011 | US20110111459 Compositions and methods for nucleic acid delivery |
| 05/12/2011 | US20110111448 Device comprising a field of tips used in biotechnology applications |
| 05/12/2011 | US20110111442 Intein-modified enzymes, their production and industrial applications |
| 05/12/2011 | US20110111423 Demethylated and / or oxidized membrane DNA |
| 05/12/2011 | US20110111420 Corn Event MIR604 |
| 05/12/2011 | US20110111408 Methods and composition for secretion of heterologous polypeptides |
| 05/12/2011 | US20110111401 Method for sequencing nucleic acid molecules |
| 05/12/2011 | US20110111398 Nucleic acid probe-based diagnostic assays targeting ssra genes of prokaryotic and eukaryotic organisms |
| 05/12/2011 | US20110111044 Nanoparticle compositions for nucleic acids delivery system |
| 05/12/2011 | US20110111041 Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells |
| 05/12/2011 | US20110110978 High titer recombinant influenza viruses with enhanced replication in vero cells |
| 05/12/2011 | US20110110970 Chimeric vaccines |
| 05/12/2011 | US20110110966 Novel immunogenic proteins of leptospira |
| 05/12/2011 | US20110110963 Gene encoding labyrinthin, a marker for cancer |
| 05/12/2011 | US20110110962 Novel Immunoadjuvant Flagellin-Based Compounds and Use Thereof |
| 05/12/2011 | US20110110955 Antibody cancer immunotherapy |
| 05/12/2011 | US20110110952 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 05/12/2011 | US20110110951 Isolation of five novel genes coding for new fc receoptrs-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/12/2011 | US20110110947 Viral chemokine-antigen fusion proteins |
| 05/12/2011 | US20110110944 Anti-alk1 antibodies and uses thereof |
| 05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |
| 05/12/2011 | US20110110935 Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS |
| 05/12/2011 | US20110110922 Wound Healing Peptides and Methods of Use Thereof |
| 05/12/2011 | US20110110917 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis |
| 05/12/2011 | US20110110915 14189, a novel human kinase and uses thereof |
| 05/12/2011 | US20110110903 Cell fusion promoter and utilization of the same |
| 05/12/2011 | US20110110902 Means and methods for counteracting, delaying and/or preventing heart disease |
| 05/12/2011 | US20110110896 Modulating levels of RNA-binding proteins for the treatment of breast cancer |
| 05/12/2011 | US20110110883 Methods of altering an immune response induced by cpg oligodeoxynucleotides |
| 05/12/2011 | US20110110857 Mutant forms of chlamydia htra |
| 05/12/2011 | US20110110852 Multivalent Antibodies and Uses Therefor |
| 05/12/2011 | US20110108420 Methods for production of proteins |
| 05/12/2011 | DE102009053566A1 Mikroorganismen mit gesteigerter Sucrosemutaseaktivität Microorganisms with enhanced Sucrosemutaseaktivität |
| 05/12/2011 | DE102009046626A1 Candida tropicalis Zellen und deren Verwendung Candida tropicalis cells and their use |
| 05/12/2011 | DE102009046623A1 Verwendung eines zu einem MeaB-Protein homologen Proteins zur Erhöhung der enzymatischen Aktivität einer 3-Hydroxycarbonsäure-CoA-Mutase Using a sequence homologous to a protein MeAB protein to increase the enzymatic activity of 3-hydroxy-CoA mutase |
| 05/12/2011 | CA2816437A1 Antibodies that specifically block the biological activity of kidney associated antigen 1 |
| 05/12/2011 | CA2790153A1 Thd primer target detection |
| 05/12/2011 | CA2780671A1 Regulated expression system |
| 05/12/2011 | CA2780247A1 Induction of apomixis in sexually reproducing cultivated plants and use for producing totally or partially apomictic plants |
| 05/12/2011 | CA2780154A1 Diagnostic assays for chordopoxviruses |
| 05/12/2011 | CA2780145A1 Therapeutic compounds |
| 05/12/2011 | CA2780143A1 Methods and composition for secretion of heterologous polypeptides |
| 05/12/2011 | CA2779839A1 T-cell stimulating protein b and methods of use |
| 05/12/2011 | CA2779796A1 Talaromyces transformants |
| 05/12/2011 | CA2779632A1 Simian adenovirus and methods of use |
| 05/12/2011 | CA2779526A1 Truncated epiderimal growth factor receptor (egfrt) for transduced t cell selection |
| 05/12/2011 | CA2779515A1 Haemophilus parasuis polypeptides and methods of use |
| 05/12/2011 | CA2779437A1 Novel viral vector construct for neuron specific continuous dopa synthesis in vivo |
| 05/12/2011 | CA2779396A1 Plants with improved nitrogen utilization and stress tolerance |
| 05/12/2011 | CA2779384A1 Engineered anti-tslp antibody |
| 05/12/2011 | CA2779339A1 Amylopectin type starch with enhanced retrogradation stability |